Alter Pharma is a Belgian group of pharmaceutical companies with headquarters in Anderlecht (Belgium) and offices in Ireland and the United States.

More information about the Group


  • Alter Pharma Board welcomes two new members

    We are very happy to announce that on 19 June 2019, Jatin Shah (Ph.D.) and Hans Stols joined the Board of Directors of Alter Pharma Group NV and Alter Pharma NV. Jatin's most recent position was Chief Scientific Officer and Executive Committee member of Perrigo Company plc, an Irish-registered developer and manufa [...]

  • New GPI Website ONLINE!

    On 29 May 2019, the new website of Generic Pharma International Ltd (GPI) was launched. GPI is the company of the generics division of the Alter Pharma Group responsible for all supply chain related activities. Click hereto go directly to the GPI website. [...]

  • Welcome to Acure Pharmaceuticals Limited as new 100% subsidiary of the Alter Pharma Group!

    On 4 April 2019, the Alter Pharma Group acquired the remaining stake in the former generics joint venture company Steac Pharmaceuticals Limited. As from then, the company based in Ireland is a 100% subsidiary of the Alter Pharma Group. At that same occasion, the name of the company was changed into Acure Pharmaceu [...]

  • Mushtaq Fruitwala joins the Alter Pharma Group as Chief Scientific Officer (US)

    We are pleased to announce that during the first quarter of 2019, Mushtaq Fruitwala has joined the team of Milla Pharmaceuticals Inc., the US based generics subsidiary of the Alter Pharma Group. Mushtaq will fill the position of Chief Scientific Officer and VP (US). Mushtaq was previously associated with Perrigo p [...]

  • CPhI Trade Fair 2018 (Madrid)

    A multi-disciplinary delegation of Neogen NV, the licensing entity of the generics division of the Alter Pharma Group,  attended the 2018 edition of the CPhI Trade Fair, which was held from 9-11 October in Madrid (Spain). Founded in 1990 as an international chemical and pharmaceutical trade fair, CPhI today is one [...]

  • New Board Member Fred Wilkinson

    We are very happy to announce that Fred Wilkinson joined the Board of Directors of Alter Pharma Group NV and Alter Pharma NV as Independent Director as from 1 October 2018. Fred’s latest position was as President of Impax, a major US generics company. Previously, he served as President, CEO, COO, etc. of a wide ra [...]

View all news